OGN:NYSE
Organon & Co
USD 13,90
arrow_upward
+0,04%(+0,0050) 1D
13 Nov., 16:00:03 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for OGN...
Open
USD 13,90
High
USD 13,90
Low
USD 13,88
Mkt. cap
3,65 mjd
Avg. vol.
2,46 m
Volume
0,00
Dividend
0,58%
Quarterly dividend
USD 0,02
Ex-dividend date
14 Aug. 2026
P/E ratio
18,08
52-wk high
USD 13,90
52-wk low
USD 5,69
EPS
USD 0,77
Beta
1,53
Shares outstanding
262,62 m
No. of employees
10 k
Open
USD 13,90
High
USD 13,90
Low
USD 13,88
Mkt. cap
3,65 mjd
Avg. vol.
2,46 m
Volume
0,00
Dividend
0,58%
Quarterly dividend
USD 0,02
Ex-dividend date
14 Aug. 2026
P/E ratio
18,08
52-wk high
USD 13,90
52-wk low
USD 5,69
EPS
USD 0,77
Beta
1,53
Shares outstanding
262,62 m
No. of employees
10 k
News stories
From web sources and news partners
marketscreener.com
·
47 minute gelede
Live Oak Acquisition Corp. VI(NasdaqGM: LOVI) added to NASDAQ Composite Index
Cryptonews.net
·
13 minute gelede
Drakewell Introduces Hedged S&P 500 Token
US News Money
·
36 minute gelede
S&P 500, Nasdaq Futures Slide as Nvidia Earnings, Anthropic Debut Loom
Business Insider
·
1 uur gelede
A veteran strategist sees a split in the stock market leading to a 15% drop in the S&P 500
Profile
Organon & Co. is an American pharmaceutical company originally founded in Oss, The Netherlands and now headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy, and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States. Wikipedia
About Organon & Co
CEO-
Employees10 k
Founded1923
HeadquartersJersey City, New Jersey, Verenigde State van Amerika
SectorHealth Care
IndustryPharmaceutical industry
Websiteorganon.com